African e-commerce company Jumia completes sale of secondary shares at $99.6M

Date:

Share post:


Almost two weeks ago, TechCrunch reported that African e-commerce giant Jumia was planning to sell 20 million American depositary shares (ADSs) and raise over $100 million, given its share price of around $5.70 at the time.

The e-tailer has now completed the at-the-market transaction offering of 20,227,736 ADSs. Jumia sold the shares at an average price of $4.92 per ADS, generating aggregate gross proceeds before commissions and offering expenses of $99.6 million. TechCrunch reported that Jumia would likely sell at that price.

Jumia CEO Francis Dufay said in a statement that the capital will “further strengthen our balance sheet and help us accelerate our growth trajectory as we progress along our path to profitability.”

Jumia’s cash position currently stands at $92.8 million (comprising $45.1 million in cash and cash equivalents and $47.7 million in term deposits and other financial assets) from its Q2 2024, its most recent financial report. That’s compared to the platform’s liquidity position of $120.6 million in Q4 2023 and $101.5 million in Q1 2024. 

Jumia finished the second quarter of the year with 2 million active quarterly customers, representing a 6.0% quarter-over-quarter compared to Q1 2024 and flat year-over-year growth between Q2 2023 and Q2 2024. “Our customer base is still relatively small, around two million active consumers per quarter, while we work in markets with over 600 million people. So we can do much more on the customer base,” Dufay told TechCrunch before undertaking his first secondary share sale as CEO earlier this month.

Between 2020 and 2021, when private and public markets were aflush with capital, the e-tailer raised almost $600 million by selling secondary shares.



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

OpenAI’s GPT-5 reportedly falling short of expectations

OpenAI’s efforts to develop its next major model, GPT-5, are running behind schedule, with results that don’t...

OpenAI announces new o3 model — but you can’t use it yet

Welcome back to Week in Review. This week, we’re looking at OpenAI’s last — and biggest —...

Google pushes back against DOJ’s ‘interventionist’ remedies in antitrust case

Google has offered up its own proposal in a recent antitrust case that saw the US Department...

If climate tech is dead, what comes next?

Humans have an innate desire to name things, but to be honest, we’re not always that good...

Hollywood angels: Here are the celebrities who are also star VCs

Becoming a venture capitalist has become the latest status symbol in Hollywood.  Everyone these days, from Olivia Wilde...

Meet Skyseed, a VC fund and incubator backing the Bluesky and AT Protocol ecosystem

On November 15, Peter Wang posted a message requesting ideas for a new incubator and fund to...

Sam Altman disputes Marc Andreessen’s description of AI meetings with Biden administration

Famed investor Marc Andreessen recently talked about meetings with Biden administration staff who gave him the impression...

EV startup Canoo places remaining employees on a ‘mandatory unpaid break’

Struggling electric van startup Canoo has placed its remaining employees on what it’s calling a “mandatory unpaid...